Position in CELC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$54,501,369
+$29,371,965 QoQ
Shares Held
520,946
+136.6% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,747,178,871 across 561 Biotechnology names. CELC ranks #35 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CELC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,501,369 | 520,946 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $25,129,404 | 220,163 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,135,890 | 81,571 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $42,211,460 | 854,483 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,129,303 | 84,592 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $689,896 | 68,239 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,098,434 | 83,914 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,092,649 | 73,283 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $616,625 | 37,645 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,065,031 | 49,307 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $769,892 | 52,841 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $118,983 | 13,018 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $146,758 | 13,366 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $51,700 | 5,044 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $71,562 | 5,108 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $43,523 | 4,335 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $48,339 | 5,312 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $65,216 | 6,975 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $488,134 | 37,008 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $604,710 | 33,595 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $720,504 | 30,021 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $433,885 | 30,257 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $240,752 | 26,283 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $116,000 | 20,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $138,600 | 20,000 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $149,207 | 22,955 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||